Use of GWAS to Identify SNPs Associated with NAFLD

Mar 22, 2021 4:00pm ‐ Mar 22, 2021 4:25pm

Genetics of NAFLD

Mar 22, 2021 4:00pm ‐ Mar 22, 2021 6:10pm

Genomics and Liver Disease in Diverse Populations: From Biobanks to Patients

Mar 22, 2021 4:25pm ‐ Mar 22, 2021 4:50pm

Short Talk: Mouse and Human Population Studies Revealed Sex-Specific Roles of Liver Pyruvate Kinase in Promoting NAFLD/NASH

Mar 22, 2021 4:50pm ‐ Mar 22, 2021 5:05pm

Short Talk: Human Hepatocyte PNPLA3 148M Exacerbates Rapid Non-Alcoholic Fatty Liver Disease Development in Chimeric Mice

Mar 22, 2021 5:05pm ‐ Mar 22, 2021 5:20pm

Coffee Break

Mar 22, 2021 5:20pm ‐ Mar 22, 2021 5:40pm

Short Talk: Hepatocyte-Specific Deletion of ROCK1 Prevents Liver Inflammation and Fibrosis in Murine Nonalcoholic Steatohepatitis

Mar 22, 2021 5:40pm ‐ Mar 22, 2021 5:55pm

Short Talk: Acetyl-CoA Metabolism Drives Epigenome Change in Steatosis Leading to Widespread Abnormal Transcription and DNA Damage

Mar 22, 2021 5:55pm ‐ Mar 22, 2021 6:10pm

The AAA Atpase Torsin A, a New, Potent Player in VLDL Secretion, NAFL, and NASH

Mar 22, 2021 6:10pm ‐ Mar 22, 2021 6:35pm

NAFLD and CVD

Mar 22, 2021 6:10pm ‐ Mar 22, 2021 7:00pm